Founded in 2019, backed by Y-Combinator, WhiteLab Genomics stands at the convergence of computer sciences and biology, pioneering the accelerated development of genomic medicines. By leveraging their proprietary technology, WhiteLab Genomics analyzes complex biological data powered by AI to significantly reduce development timelines and mitigate associated risks. Based on exhaustive datasets, the platform provides in-silico simulations to discover, and design optimized payloads and vectors. WhiteLab aims to expedite the drug development process, cut costs, and accelerate the delivery of life-saving therapies to the market. The company collaborates with leading pharmaceutical companies such as Sanofi, academic institutions, and innovative biotechnology companies. Recognized for their contribution to advancing the field of gene and cell therapy, WhiteLab Genomics is part of the prestigious French government supported by French Tech 2030 program and recently joined the Bayer Co.Lab in Cambridge, MA, and Ginkgo Bioworks' Technology Network, marking major milestones in our international expansion.
Company Details
- Employees
- 51
- Founded
- -
- Address
- Paris, Ile De France 75000, Fr
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://whitelabgx.com/
- Keywords
- de la médecine personnalisée..
- HQ
- Paris, Ile de France
Whitelab Genomics Questions
Whitelab Genomics's website is https://whitelabgx.com/
Whitelab Genomics's LinkedIn profile is https://www.linkedin.com/company/whitelabgenomics
Whitelab Genomics has
51 employees.
View email and phone details for 51
employees at Whitelab Genomics.
Whitelab Genomics's industry is
Biotechnology Research
Whitelab Genomics's top competitors are
Smart Immune,
Qubit Pharmaceuticals,
Aqemia,
Iktos,
Everzom,
Okomera,
Owkin,
Orakl Oncology,
Future4care,
Bioptimus.
Whitelab Genomics's categories are Biotechnology Research
Whitelab Genomics's founding year is 2019
